1. Yki-Jarvinen H. Thiazolidinediones. N Engl J Med. 2004;351(11):1106–18.
2. US Food and Drug Administration. Safety alerts for human medical products: Rezulin (troglitazone) (2000). http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm173081.htm . Accessed 14 Jun 2013.
3. European Medicines Agency. European Medicines Agency recommends suspension of Avandia, Avandamet and Avaglim (2010). http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2010/09/WC500096996.pdf . Accessed 14 Jun 2013.
4. US Food and Drug Administration. Approved drug products: Actos (pioglitazone hydrochloride) (1999). http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails . Accessed 14 Jun 2013.
5. European Medicines Agency. European public assessment reports: product information for Actos (2013). http://www.emea.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000285/WC500021386.pdf . Accessed 14 Jun 2013.